May 24, 2007 (San Diego) — A recent study found that among patients in a psychiatric hospital, the atypical antipsychotic quetiapine (Seroquel, AstraZeneca), which is approved for schizophrenia and ...
Off-label prescribing is when a medication is prescribed for a purpose not approved by the FDA. Insurance might cover off-label prescriptions, but it depends on the specific plan and often requires a ...
Most migraine management is off-label, doctors say. Sept. 10, 2010 -- Migraine sufferers like Barbara Trupin, who endured the severe headaches weekly for almost 20 years, will often do anything to get ...
ABILENE, Texas — Ozempic, an injectable drug used to control high blood sugar, is a helpful tool for type 2 diabetics - but one of the side effects of the drug has caused viral interest beyond just ...
An off-label prescription drug has been shown to help some non-verbal children with autism discover the ability to speak. The drug, leucovorin, is a prescription vitamin that functions similarly to ...
A new study finds that off-label drug use is associated with higher rates of adverse drug events in adults. Off-label use of prescription drugs is known to be associated with adverse drug events (ADEs ...
One of the most alarming things about COVID-19 is that there are no FDA-approved drugs to fight it. Instead, doctors have turned to medications such as azithromycin, chloroquine, hydroxychloroquine, ...
It can be linked to other problems, too, such as type 2 diabetes, cardiovascular disease and infertility, and is known to have a knock-on effect on the self-esteem and mental health of the sufferer.
When Pfizer’s COVID-19 vaccine was approved in August, it was only approved for ages 16 and up as a two-dose series. But since fully-approved vaccines and medications can be used “off label,” many of ...
Although Topamax is not FDA approved for weight loss, doctors may prescribe the drug off-label. Studies show that people taking Topamax for 24 weeks lose about 4.5% to 6.5% of body weight. Topamax may ...
The hype around the off-label use of the immunosuppressant rapamycin to prevent aging and increase longevity could be unfounded. This is the warning of researchers who have critically explored ...